Janux Therapeutics, Bristol Myers Squibb Enter Up to $850 Million Cancer Drug Deal
Janux Therapeutics has entered into a collaboration and licensing agreement with Bristol Myers Squibb (BMS) valued at up to USD […]
Pharma
GSK Acquires Rapt Therapeutics in $2.2 Billion Deal for Food Allergy Drug
GSK has agreed to acquire Rapt Therapeutics in a transaction valued at approximately USD 2.2 billion, securing rights to the […]
Novavax Licenses Matrix-M Vaccine Technology to Pfizer in Strategic Development Deal
Novavax has entered into a licensing agreement with Pfizer that allows the global pharmaceutical major to use Novavax’s Matrix-M adjuvant […]
Novo Nordisk Expands Cell Therapy Partnership with Aspect Biosystems for Diabetes
Novo Nordisk has expanded its collaboration with Aspect Biosystems to accelerate the development of cell-based therapies for diabetes, strengthening a […]
Pfizer to Exit ViiV Healthcare in $1.9 Billion Deal; Shionogi Doubles Stake
Pfizer will exit ViiV Healthcare through a transaction valued at approximately USD 1.9 billion, leading to a major change in […]
Budget 2026: Pharma Industry Eyes Duty Cuts, R&D Support and Preventive Care Boost
As the Union Budget 2026 approaches, the pharmaceutical industry is seeking policy measures focused on customs duty rationalisation, increased R&D […]
Sun Pharma Launches Unloxcyt in US, Expanding Access to Advanced Cancer Care
Mumbai-based Sun Pharmaceutical Industries Ltd. has announced the commercial launch of Unloxcyt (cosibelimab-ipdl) in the United States following an updated […]
Lantern Pharma Expands Global AI Footprint with Bengaluru Center of Excellence
Lantern Pharma Inc. has announced the establishment of an Artificial Intelligence (AI) Center of Excellence and Advanced Agentic Labs in […]
Bayer AG Targets Return to Mid-Single-Digit Pharma Growth by 2027
Bayer AG has set a target to return its pharmaceuticals business to mid-single-digit sales growth by 2027, as the company […]
Zydus Lifesciences Launches Denosumab Biosimilar Zyrifa in India
Zydus Lifesciences has launched a Denosumab biosimilar in India, expanding its oncology and biologics portfolio and strengthening access to bone-health […]
Haleon Names Kedar Lele as India Subcontinent President, Signalling Strategic Push in Consumer Health and OTC Pharma
Haleon (formerly GSK Consumer Healthcare India) on Friday announced the appointment of Kedar Lele as President, India Subcontinent, reinforcing the […]
Thermo Fisher Scientific to Acquire Clario in $8.875 Billion Deal, Strengthening Digital Clinical Research Capabilities
Thermo Fisher Scientific Inc. has announced a definitive agreement to acquire Clario Holdings Inc., a leading provider of digital endpoint […]
Insilico Medicine and Servier Forge US$888 Million Oncology Partnership to Advance AI-Led Drug Discovery
Insilico Medicine has entered into a multi-year strategic collaboration with Servier, valued at up to US$888 million, aimed at accelerating […]
